Cite
APA Citation
Lee, E. Q., Muzikansky, A., Duda, D. G., Gaffey, S., Dietrich, J., Nayak, L., Chukwueke, U. N., Beroukhim, R., Doherty, L., Laub, C. K., LaFrankie, D., Fontana, B., Stefanik, J., Ruland, S., Caruso, V., Bruno, J., Ligon, K., Reardon, D. A., & Wen, P. Y. (n.d.). phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma. Cancer medicine, 8, 5988–5994. http://access.bl.uk/ark:/81055/vdc_100092807444.0x000011